Pharmaceutical Patent Protection in Turkey

Gaye Ramazanoglu, Intellectual Property Specialist, Sanovel, Turkey

Between 1994 and 1995, Turkey conducted necessary legislative studies to establish an efficient and contemporary industrial property system and obtained very important concrete results. Turkey has ratified many international agreements regarding the IP system and as a result of this, pharmaceutical products and their process procedures have also started to be protected by Intellectual Property (IP) rights since 1st January 1999. This means an important Turkish Industrial Property Revolution. The international agreements regarding the IP system are, PCT (Patent Cooperation Treaty) which has come into force in 1st January 1996 and the EPC (European Patent Convention) in 1st November 2000. As a result of these changes, Turkey has some problems as other developing countries during the transition periods concerning their IP system.

Read full paper Subscribe to the IICJ
Turkey Intellectual Property Pharmaceutical June 2011 Vol. 4, No. 15, Spring 2011

Gaye Ramazanoglu

More

Gaye Ramazanoglu graduated from Marmara University, Faculty of Pharmacy in 2000. Started working for Roche Pharmaceuticals-Istanbul in September 2000 as Quality Control Analyst and later on worked as Analytical Method Validation Responsible and as Quality Assurance Specialist until February 2006. Then started working for Sanovel Pharmaceuticals-Istanbul as Intellectual Property Specialist at March 2006 and since then working still there. In 2007, took the Turkish national patent and trademark exams and passed in first trial to be a Patent and Trademark Attorney. Gaye Ramazanoglu has a certificate from CEIPI (Centre for International Intellectual Property Studies) which is based in Strasbourg Law Faculty, about `Basic Training for the European Patent Law` (this course was held between 2008-2010 at Istanbul) Gaye has a certificate from EPO (European Patent Office) as a `Praktika Intern`. In addition trained at DG1 - Pure and Applied Organic Chemistry Cluster in EPO, Munich (Germany) for 3 weeks in November, 2009.

Sanovel

More

Sanovel Ilac (Pharmaceuticals) is the fastest growing company in the Turkish pharmaceutical market, was been established in 1983 by Pharmacist Erol Toksoz and has grown to be the flagship company in core business of Toksoz Group that manufactures, markets and distributes pharmaceutical products. Moving up in IMS ranking to be among top ten companies over the last decade, Sanovel has proven success record of developing and introducing value added and patented generic products to market in all vital therapeutic areas. Furthermore, Sanovel serves in animal health with its veterinary products. While growing in Turkey, Sanovel is also moving towards international recognition. Branch offices are already established in CIS, Ukraine and Russian Federation. Export to Georgia and Azerbaijan has started in 2005. At the same time the project for presence in EU and USA is also moving forward with companies established in Netherland (Adilna Sanovel Holding B.V.), France (Sanovel S.A.S), Germany (Sanovel GmbH) and Bulgaria (Sanovel L.L.C).

Turkey Intellectual Property Pharmaceutical June 2011 Vol. 4, No. 15, Spring 2011
rolex